| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.44T | 3.07T | 3.21T | 3.32T | 2.74T |
| Gross Profit | 74.08B | 502.78B | 641.45B | 632.19B | 662.83B |
| EBITDA | 110.18B | 207.68B | 214.65B | 219.97B | 238.73B |
| Net Income | 31.64B | 48.94B | 58.31B | 66.93B | 71.97B |
Balance Sheet | |||||
| Total Assets | 2.15T | 2.08T | 2.02T | 1.95T | 1.89T |
| Cash, Cash Equivalents and Short-Term Investments | 150.94B | 148.20B | 165.76B | 148.56B | 227.93B |
| Total Debt | 597.72B | 475.69B | 440.23B | 356.70B | 315.52B |
| Total Liabilities | 1.17T | 1.11T | 1.07T | 1.01T | 974.18B |
| Stockholders Equity | 827.82B | 815.82B | 802.99B | 784.71B | 774.18B |
Cash Flow | |||||
| Free Cash Flow | 33.78B | 10.15B | -10.02B | -37.48B | 80.25B |
| Operating Cash Flow | 163.95B | 149.36B | 161.47B | 116.27B | 225.17B |
| Investing Cash Flow | -148.17B | -161.24B | -155.87B | -95.01B | -145.20B |
| Financing Cash Flow | -25.57B | -19.24B | 22.73B | -39.70B | -57.94B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$1.31T | 7.65 | 16.65% | 6.76% | -9.81% | -8.84% | |
75 Outperform | HK$2.45T | 8.75 | 10.04% | 6.32% | -6.92% | -2.57% | |
74 Outperform | HK$1.13T | 13.10 | 13.43% | 8.97% | -13.87% | -15.41% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
63 Neutral | HK$70.70B | 7.80 | 8.45% | 3.59% | 2.58% | 7.10% | |
50 Neutral | HK$756.99B | 16.07 | 4.09% | 5.52% | -10.02% | -27.89% | |
45 Neutral | HK$28.58B | -8.27 | -5.96% | 1.65% | -11.11% | 62.07% |